indoximod 1-methyl-d-tryptophan 1mt nlg-8189 (NewLink Genetics)
90
Structured Review
NewLink Genetics
indoximod 1-methyl-d-tryptophan 1mt nlg-8189
Indoximod 1 Methyl D Tryptophan 1mt Nlg 8189, supplied by NewLink Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d-1mt/indoximod+nlg+8189/pm37509627-124-0-14
Average 90 stars, based on 1 article reviews
Indoximod 1 Methyl D Tryptophan 1mt Nlg 8189, supplied by NewLink Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d-1mt/indoximod+nlg+8189/pm37509627-124-0-14
Average 90 stars, based on 1 article reviews
indoximod 1-methyl-d-tryptophan 1mt nlg-8189 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Incyte's big IDO Article Snippet: In May, Huttunen and colleagues reported that overexpression of IDO was associated with poor outcomes in sepsis.5 Noting that IDO inhibition has potential in chronic infectious diseases such as HIV and Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: Article Title: Indoleamine 2,3-dioxygenase 1 (IDO1) Article Snippet: Article Title: B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase Article Snippet: We thank Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: We also thank Coley Pharmaceuticals and Injection:Article Title: Incyte's big IDO Article Snippet: In May, Huttunen and colleagues reported that overexpression of IDO was associated with poor outcomes in sepsis.5 Noting that IDO inhibition has potential in chronic infectious diseases such as HIV and Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: Article Title: Indoleamine 2,3-dioxygenase 1 (IDO1) Article Snippet: Article Title: B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase Article Snippet: We thank Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: We also thank Coley Pharmaceuticals and Over Expression:Article Title: Incyte's big IDO Article Snippet: In May, Huttunen and colleagues reported that overexpression of IDO was associated with poor outcomes in sepsis.5 Noting that IDO inhibition has potential in chronic infectious diseases such as HIV and Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: Article Title: Indoleamine 2,3-dioxygenase 1 (IDO1) Article Snippet: Article Title: B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase Article Snippet: We thank Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: We also thank Coley Pharmaceuticals and Inhibition:Article Title: Incyte's big IDO Article Snippet: In May, Huttunen and colleagues reported that overexpression of IDO was associated with poor outcomes in sepsis.5 Noting that IDO inhibition has potential in chronic infectious diseases such as HIV and Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: Article Title: Indoleamine 2,3-dioxygenase 1 (IDO1) Article Snippet: Article Title: B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase Article Snippet: We thank Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: We also thank Coley Pharmaceuticals and In Vitro:Article Title: Incyte's big IDO Article Snippet: In May, Huttunen and colleagues reported that overexpression of IDO was associated with poor outcomes in sepsis.5 Noting that IDO inhibition has potential in chronic infectious diseases such as HIV and Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: Article Title: Indoleamine 2,3-dioxygenase 1 (IDO1) Article Snippet: Article Title: B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase Article Snippet: We thank Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: We also thank Coley Pharmaceuticals and In Vivo:Article Title: Incyte's big IDO Article Snippet: In May, Huttunen and colleagues reported that overexpression of IDO was associated with poor outcomes in sepsis.5 Noting that IDO inhibition has potential in chronic infectious diseases such as HIV and Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: Article Title: Indoleamine 2,3-dioxygenase 1 (IDO1) Article Snippet: Article Title: B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase Article Snippet: We thank Article Title: Physiologic control of IDO-competence in splenic dendritic cells Article Snippet: We also thank Coley Pharmaceuticals and |
![IDO-blockade synergizes with chemo-radiation therapy. Orthotopic GL261 glioblastoma tumors were implanted stereotactically into the right frontal lobes of syngeneic C57BL/6 host mice. Kaplan-Meier survival plots are shown, comparing mice treated with: A , temozolomide plus radiation (TMZ + RT) and with or without IDO-blockade using <t>DL-1MT;</t> B , TMZ + RT and with or without IDO-blockade using NLG919 or D-1MT; C , cyclophosphamide plus RT (CPM + RT) and with or without DL-1MT; or D , with CPM + RT plus either D-1MT or DL-1MT. IDO-blocking drugs (DL-1MT, 4 mg/mL; NLG919, 6 mg/mL; or D-1MT, 4 mg/mL) were supplied in drinking water continuously starting at day 7 after tumor implantation; chemotherapy (TMZ, 100 mg/kg, i.p.; or CPM, 100 mg/kg, i.p.) was given on day 9, and RT (500 cGy) was given on day 10. For reference, each survival plot contains a cohort of untreated mice, and mice treated with IDO-blockade using DL-1MT alone are shown in A . Cohort sizes (n) are indicated for each treatment group and represent pooled data from multiple experiments containing 1–3 mice from each group per experiment. n.s., not significant [vs. untreated mice (A) ; or DL-1MT vs. D-1MT (D) ]; *, P < 0.001 (vs. untreated mice); **, P < 0.002 (vs. mice treated with chemo-radiation alone), by log-rank test.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5871/pmc04105871/pmc04105871__2051-1426-2-21-1.jpg)
